Stereotaxis Inc (STXS) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Stereotaxis Inc   (NYSEAMER: STXS)
 

Stereotaxis Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Stereotaxis Inc 's inventory turnover ratio sequentially decreased to 1.23 in the second quarter 2026, unsurprisingly, as the Stereotaxis Inc markets continue to deteriorate, and STXS's faces growing challenges to bring down its inventories. Stereotaxis Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 297 days, from 259 days, in the Mar 31 2026 quarter.

Within Healthcare sector 291 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1748, from total ranking in the first quarter 2026 at 1912.

STXS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Stereotaxis Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

STXS Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 30.31 % 6.96 % 14.84 % 12.63 % 3.49 %
Y / Y Cost of Sales Growth -20.4 % -33.33 % 25 % -40 % 300 %
Inventory Turnover Ratio (TTM) 1.23 1.41 1.53 1.48 1.74
STXS's Total Ranking # 1748 # 1912 # 1788 # 1695 # 1808
Average inventory processing period 296 260 238 247 210
Seq. Inventory Growth 19.29 % 9.7 % -5.72 % 5.61 % -2.08 %
Seq. Cost of Sales Growth 59.2 % -60 % 66.67 % -25 % 33.33 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 135
Healthcare Sector # 292
Overall Market # 1748

Inventory Turnover Ratio Statistics
High Average Low
7.24 2.2 1.05
(Sep 30 2018)   (Jun 30 2024)



STXS Company Profile >> Back to STXS Efficiency Comparisons >> Compare STXS Inventory Turnover Ratio to its Competitors

Financial Statements
Stereotaxis Inc 's Inventories $ 13 Millions Visit STXS's Balance sheet
Stereotaxis Inc 's Cost of Revenues TTM $ 13 Millions Visit STXS's Income Statement
What are STXS's Sales? Visit STXS's Sales by Segment

Other Inventory Turnover Ratios
Stereotaxis Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
STXS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for STXS's Competitors
Inventory Turnover Ratio for STXS's Suppliers
Inventory Turnover Ratio for STXS's Customers

You may also want to know
STXS's Sales Growth Rates STXS's Pe Price to earnings ratio STXS's Receivables Turnover Ratio STXS's Stock Quote
STXS's Net Income Growth Rates STXS's Ps Price to Sales ratio STXS's Sales per Employee STXS's Asset Turnover Ratio
STXS's Net Margin STXS's Pb Price to Book ratio STXS's Financial Strength Ratios STXS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Iovance Biotherapeutics inc   2.81 $ 152.872  Millions$ 54  Millions
Livanova Plc  2.79 $ 468.065  Millions$ 168  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Dentsply Sirona Inc   2.77 $ 1,839.000  Millions$ 663  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
International Stem Cell Corporation  2.61 $ 4.285  Millions$ 2  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions
Nephros Inc   2.54 $ 8.991  Millions$ 4  Millions
Illumina Inc   2.52 $ 1,510.000  Millions$ 599  Millions
IMPACT BIOMEDICAL INC.  2.46 $ 0.414  Millions$ 0  Millions
Quidelortho Corp  2.45 $ 1,481.500  Millions$ 605  Millions
Perrigo Company Plc  2.43 $ 2,775.900  Millions$ 1,140  Millions
Pro dex Inc   2.43 $ 53.213  Millions$ 22  Millions
Angiodynamics Inc   2.43 $ 142.834  Millions$ 59  Millions
Cytosorbents Corporation  2.43 $ 10.584  Millions$ 4  Millions
Journey Medical Corp  2.42 $ 23.556  Millions$ 10  Millions
Aquestive Therapeutics Inc   2.42 $ 17.828  Millions$ 7  Millions
Viatris Inc   2.41 $ 9,604.200  Millions$ 3,993  Millions
Electrocore Inc   2.40 $ 4.346  Millions$ 2  Millions
Cannapharmarx Inc   2.37 $ 2.483  Millions$ 1  Millions
Aurinia Pharmaceuticals Inc   2.34 $ 30.036  Millions$ 13  Millions
Fortress Biotech Inc   2.34 $ 22.768  Millions$ 10  Millions
Scientific Industries Inc   2.33 $ 4.057  Millions$ 2  Millions
Resmed Inc   2.33 $ 2,176.428  Millions$ 933  Millions
Insight Molecular Diagnostics Inc   2.31 $ 0.868  Millions$ 0  Millions
Tela Bio Inc   2.30 $ 26.348  Millions$ 11  Millions
Sanara Medtech Inc   2.29 $ 7.981  Millions$ 3  Millions

Date modified: 2026-09-04T00:11:03+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.